Predictors of Clinical Course and Treatment Response in DBT Programmes

Launched by OSLO UNIVERSITY HOSPITAL · Mar 20, 2020

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how different factors can affect the treatment and recovery of patients with Borderline Personality Disorder (BPD) who have a history of self-harm. It involves a partnership between The National Centre for Suicide Research and Prevention and various clinics that provide Dialectical Behaviour Therapy (DBT), which is a type of therapy designed to help individuals manage their emotions and improve their relationships. The study will collect data from patients in DBT programs in Norway to identify what influences their progress and how well they respond to treatment.

To participate in the trial, individuals must have a history of repeated self-harm and meet specific criteria for BPD as defined by a structured interview. Unfortunately, those with certain conditions, like severe mental disorders or substance dependence, cannot join. Participants can expect to receive high-quality treatment while contributing to valuable research that may help improve future care for others facing similar challenges. This study is currently recruiting participants of all genders, aged between 18 and 65.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • History of repeated deliberate self harm
• • Satisfies criteria of Diagnostic and Statistical Manual (DSM-IV) Borderline Personality Disorder as measured by Structured Clinical Interview for the DSM (SCID-II) in addition to the self-destructive criterion.
• Exclusion Criteria:
• • Psychotic disorders
• • Anorexia Nervosa
• • Substance dependence disorder
• • Mental retardation (IQ less than 70)
• • Asperger syndrome/autism